Warning regarding Toyodo Pharmaceutical Co., Ltd., which solicits the purchase of corporate bonds by falsely claiming to be engaged in business such as manufacturing and selling generic drugs.

Since March 2016, consultations related to businesses that solicit the purchase of unsecured convertible bonds with stock acquisition rights under the false pretense that they are engaged in businesses such as the manufacture and sale of generic drugs have become commonplace among consumers in various regions. sent to the center.
Based on the provisions of Article 38, Paragraph 1 of the Consumer Safety Act (Act No. 50 of 2009), the Consumer Affairs Agency has issued a notice of unfair harm to the interests of consumers in transactions with Toyodo Pharmaceutical Co., Ltd. In order to prevent the occurrence or expansion of consumer damage, we will notify consumers.
For details, please see the Consumer Affairs Agency website.